Sponsored

Holiday Ready Treatments? Reduce downtime. Improve Outcomes.

omni_si2009_lead

Holiday Ready Treatments?

Reduce Downtime. Improve Outcomes.

Omni TaC Core Recovery Complex 

As patients return and prepare for holiday-ready skin, Omni TaC Core Recovery Complex is the critical final step in post ablative laser, micro-needling, peels and other aesthetic treatments for reduced downtime, less inflammation and improved patient skin quality.

The professional’s choice for post-treatment recovery, this scientifically formulated proprietary serum of concentrated medical grade human growth factors and cytokines encourages the transformation of skin to an improved youthful state with less downtime, enhancing ablative laser, micro-needling and chemical peels. With Omni’s ProYouth proprietary, patented science, TaC Core Recovery Complex not only reduces downtime, it helps to improve the appearance of damaged, aging and post-procedure skin.

And the improvement continues well after treatment. With a cumulative impact, this scientific breakthrough improves the skin’s quality, appearance and glow weeks after treatment, supporting skin health between in-office treatments.

Why Growth Factors

The goal of growth factor technology is to provide the skin with support of biologic signaling that mimics our own regenerative system, while encouraging healthy cellular turn over and protecting against inflammation, particularly important following ablative laser, or micro-needling treatments. All the while reducing redness, inflammation and downtime while improving skin quality outcomes.

 

Not All Growth Factors are Equal

While growth factors have many jobs and attributes, most growth factor formulas may actually contain growth factors that are non-human derived such as plant or fruit. Others are a combination of inflammatory and anti-inflammatory proteins. The industry challenge has been to target and extract the anti-inflammatory bio-signals to gain the benefit of growth factor skin improvements without the extra inflammation post procedure. Until now…

The Omni Innovation: Proprietary, Patented Targeted Anti-Inflammatory Growth FactorsThe Omni Innovation: Proprietary, Patented Targeted Anti-Inflammatory Growth Factors

Only Omni’s human derived growth factor serum uses a unique patented breakthrough innovation process that allows for the extraction of anti-inflammatory bio-signals, targeting specific growth factors including FGF, VEGF and TGF-b, known to contribute to wound healing. This is particularly important following ablative laser, or micro-needling treatments to reduce redness, inflammation and downtime while improving skin quality.

BenefitsBenefits

Patient concerns about downtime, redness, irritation and discomfort with ablative lasers, micro-needling and peels are mitigated as Omni TaC Core Recovery Complex:

  • Encourages rapid recovery of the skin post laser, skin resurfacing, micro-needling and peels
  • Reduces inflammation and downtime
  • Improves overall skin quality and has a cumulative effect for weeks after the in-office treatment 

 

About OmniAbout Omni

Backed by an extraordinary collaboration of scientists, forward-thinking physicians and labs, Omni Bioceutical Innovations produces superior growth factors, peptides and other proteins for use in skin and hair products. Using the highest quality fibroblast derived growth factors, our groundbreaking products dramatically reduce downtime, aid in cell regeneration and calm inflammation.

Learn more about Omni products, available exclusively thru Omni skincare professionals, for post-procedure and between-treatments “at home” care: omnibioinnovations.com.

Disclaimer:

The above paid-for content was produced by and posted on behalf of the Sponsor. Content provided is generated solely by the Sponsor or its affiliates, and it is the Sponsor’s responsi­bility for the accuracy, completeness and validity of all information included. Skin Inc. takes steps to ensure that you will not confuse sponsored content with content produced by Skin Inc. and governed by its editorial policy.

More in Facial